Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, and fellowship in cardiology at the Hospital of the University of Pennsylvania. His first faculty appointment was at Allegheny General Hospital, then MCP/Hahnemann University School of Medicine, where he directed the cardiology fellowship. He then moved to the University of Virginia School of Medicine, where in 2019 he was named the George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, Chief of the Division of Cardiovascular Medicine, and Medical Director of the Heart and Vascular Science Line. Kramer's principal research interest has been the application of cardiovascular magnetic resonance (CMR) to the cardiovascular system in clinical and translational studies. Prior to serving as ACC President, Kramer served as President of the Society for Cardiovascular Magnetic Resonance (SCMR), ACC Treasurer and Vice President, Chair of ACC's Imaging Council, and Chair of the Clinical and Integrative Cardiovascular Sciences NIH study section. Kramer was an associate editor at JACC and previously was Executive Editor of JACC: Cardiovascular Imaging. He currently serves on the editorial boards of Circulation, Circulation: Cardiovascular Imaging and Vascular Medicine. Kramer is also a member of the American Society for Clinical Investigation, Association of University Cardiologists and American Association of Physicians. He received the Gold Medal from the Society for Cardiovascular Magnetic Resonance in 2015 and was named a Distinguished Mentor by the ACC in 2021. Chris is joining this year's ASM representing the American College of Cardiology, in his role as President.

Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, and fellowship in cardiology at the Hospital of the University of Pennsylvania. His first faculty appointment was at Allegheny General Hospital, then MCP/Hahnemann University School of Medicine, where he directed the cardiology fellowship. He then moved to the University of Virginia School of Medicine, where in 2019 he was named the George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, Chief of the Division of Cardiovascular Medicine, and Medical Director of the Heart and Vascular Science Line. Kramer's principal research interest has been the application of cardiovascular magnetic resonance (CMR) to the cardiovascular system in clinical and translational studies. Prior to serving as ACC President, Kramer served as President of the Society for Cardiovascular Magnetic Resonance (SCMR), ACC Treasurer and Vice President, Chair of ACC's Imaging Council, and Chair of the Clinical and Integrative Cardiovascular Sciences NIH study section. Kramer was an associate editor at JACC and previously was Executive Editor of JACC: Cardiovascular Imaging. He currently serves on the editorial boards of Circulation, Circulation: Cardiovascular Imaging and Vascular Medicine. Kramer is also a member of the American Society for Clinical Investigation, Association of University Cardiologists and American Association of Physicians. He received the Gold Medal from the Society for Cardiovascular Magnetic Resonance in 2015 and was named a Distinguished Mentor by the ACC in 2021. Chris is joining this year's ASM representing the American College of Cardiology, in his role as President.

Dr Belinda Gray is a Cardiologist at Royal Prince Alfred Hospital in Sydney and Associate Professor in the Faculty of Medicine and Health at University of Sydney. She is a Heart Foundation Future Leadership Fellow. Dr Gray completed her PhD in Genetic Heart Disease at University of Sydney and postdoctoral fellowship in Inherited Cardiac Conditions and Sports Cardiology at St George’s, University of London, UK. Dr Gray’s research focuses on risk stratification, genetics and prevention of sudden cardiac death in the young, including young athletes.

John Atherton (MBBS, PhD, FRACP, FCSANZ, FHFA) is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH) and Professor, Faculty of Medicine, University of Queensland. Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines and is a European Society of Cardiology Heart Failure Association Ambassador. He chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, sits on the Therapeutic Guidelines Cardiovascular Expert Group and co-authored the first universal definition of heart failure. Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR)- Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include investigating novel methods to detect pre-symptomatic heart disease, heart failure disease management, hypertrophic cardiomyopathy and cardiac genetics.